| Pharmaceutical Information |
| Drug Name |
Mebeverine |
| Drug ID |
BADD_D01354 |
| Description |
Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms. |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
A03AA04 |
| DrugBank ID |
DB12554
|
| KEGG ID |
D08160
|
| MeSH ID |
C005096
|
| PubChem ID |
4031
|
| TTD Drug ID |
D0VU8Q
|
| NDC Product Code |
Not Available |
| Synonyms |
mebeverine | 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate | duspatalin | spasmotalin | mebeverine hydrochloride |
|
| Chemical Information |
| Molecular Formula |
C25H35NO5 |
| CAS Registry Number |
3625-06-7 |
| SMILES |
CCN(CCCCOC(=O)C1=CC(=C(C=C1)OC)OC)C(C)CC2=CC=C(C=C2)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
